The DOI matches its Crossref record.
Estimating age‐specific cumulative incidence for the 2009 influenza pandemic: a meta‐analysis of A(H 1 N 1)pdm09 serological studies from 19 countries
Open accessAbstract
Background: The global impact of the 2009 influenza A(H 1 N 1) pandemic (H 1 N 1pdm) is not well understood. Objectives: We estimate overall and age‐specific prevalence of cross‐reactive antibodies to H 1 N 1pdm virus and rates of H 1 N 1pdm infection during the first year of the pandemic using data from published and unpublished H 1 N 1pdm seroepidemiological studies. Methods: Primary aggregate H 1 N 1pdm serologic data from each study were stratified in standardized age groups and evaluated based on when sera were collected in relation to national or subnational peak H 1 N 1pdm activity. Seropositivity was assessed using well‐described and standardized hemagglutination inhibition (HI titers ≥32 or ≥40) and microneutralization (MN ≥ 40) laboratory assays. The prevalence of cross‐reactive antibodies to the H 1 N 1pdm virus was estimated for studies using sera collected prior to the start of the pandemic (between 2004 and A pril 2009); H 1 N 1pdm cumulative incidence was estimated for studies in which collected both pre‐ and post‐pandemic sera; and H 1 N 1pdm seropositivity was calculated from studies with post‐pandemic sera only (collected between D ecember 2009–J une 2010). Results: Data from 27 published/unpublished studies from 19 countries/administrative regions – A ustralia, C anada, C hina, F inland, F rance, G ermany, H ong K ong SAR, I ndia, I ran, I taly, J apan, N etherlands, N ew Z ealand, N orway, R eunion I sland, S ingapore, U nited K ingdom, U nited S tates, and V ietnam – were eligible for inclusion. The overall age‐standardized pre‐pandemic prevalence of cross‐reactive antibodies was 5% (95%CI 3–7%) and varied significantly by age with the highest rates among persons ≥65 years old (14% 95%CI 8–24%). Overall age‐standardized H 1 N 1pdm cumulative incidence was 24% (95%CI 20–27%) and varied significantly by age with the highest in children 5–19 (47% 95%CI 39–55%) and 0–4 years old (36% 95%CI 30–43%). Conclusions: Our results offer unique insight into the global impact of the H 1 N 1 pandemic and highlight the need for standardization of seroepidemiological studies and for their inclusion in pre‐pandemic preparedness plans. Our results taken together with recent global pandemic respiratory‐associated mortality estimates suggest that the case fatality ratio of the pandemic virus was approximately 0·02%.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Hayward, A. C., Fragaszy, E. B., Bermingham, A., Wang, L., Copas, A., Edmunds, W. J., Ferguson, N., Goonetilleke, N., Harvey, G., Kovar, J., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70034-7 · Cited by 407
Lycett, S. J., Duchatel, F., & Digard, P. (2019) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2018.0257 · Cited by 255
(2022) · doi:10.1503/cmaj.221335 · Cited by 69
Temime, L., Cohen, N., Ait-Bouziad, K., Denormandie, P., Dab, W., & Hocine, M. N. (2018) · American Journal of Infection Control · doi:10.1016/j.ajic.2017.08.030 · Cited by 27
Metadata
- Authors
- Van Kerkhove, M. D., Hirve, S., Koukounari, A., Mounts, A. W., & for the H1N1pdm serology working group
- Venue
- Influenza and Other Respiratory Viruses
- Publisher
- Wiley
- Published
- 2013-01-21
- Volume
- 7
- Issue
- 5
- Pages
- 872-886
- ISSN
- 1750-2640 (ISSN-L)
- 1750-2659
- OpenAlex
- W1971279413
- Cited by
- 175
- References
- 0
- FWCI
- 15.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estimating age‐specific cumulative incidence for the 2009 influenza pandemic: a meta‐analysis of A(H 1 N 1)pdm09 serological studies from 19 countries. https://app.cochat.ai/papers/10.1111/irv.12074
- The paper
- Van Kerkhove, M. D., Hirve, S., Koukounari, A., Mounts, A. W., & for the H1N1pdm serology working group. (2013). Estimating age‐specific cumulative incidence for the 2009 influenza pandemic: a meta‐analysis of A(H 1 N 1)pdm09 serological studies from 19 countries. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.12074
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.